{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:30:54Z","timestamp":1788917454550,"version":"build-2803163510"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"1100","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:p>The myocardium and the cardiovascular system are often involved in patients with sarcoidosis. As therapy should be started as early as possible to avoid complications such as left ventricular dysfunction, a prompt and reliable diagnosis by means of non-invasive tests would be highly warranted. Among other techniques, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has emerged as a high sensitive tool to detect sites of inflammation before morphological changes are visible to conventional imaging techniques. We therefore aim at summarizing the most relevant findings in the literature on the use of 18F-fluorodeoxyglucose PET in the diagnostic workup of cardiac sarcoidosis and to underline future perspectives.<\/jats:p>","DOI":"10.1259\/bjr.20190247","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T20:13:35Z","timestamp":1559765615000},"source":"Crossref","is-referenced-by-count":22,"title":["The role of positron emission tomography in the assessment of cardiac sarcoidosis"],"prefix":"10.1093","volume":"92","author":[{"given":"Dario","family":"Genovesi","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit, Fondazione CNR\/Regione Toscana \"Gabriele Monasterio\" , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino , Genova , Italy"},{"name":"Department of Health Sciences (DISSAL), University of Genova , Genoa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Altini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Interdisciplinar Department of Medicine, Policlinic of Bari- University of Bari \u201cAldo Moro\u201d , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Elena","family":"Popescu","sequence":"additional","affiliation":[{"name":"Clinic of Nuclear Medicine, Baden Hospital , Baden , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ferro","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, IRCCS San Raffaele Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Monaco","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University Milan Bicocca , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Borra","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genova , Genoa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Interdisciplinar Department of Medicine, Policlinic of Bari- University of Bari \u201cAldo Moro\u201d , Bari , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-775X","authenticated-orcid":false,"given":"Federico","family":"Caobelli","sequence":"additional","affiliation":[{"name":"Clinic of Radiology & Nuclear Medicine, University Hospital Basel, University of Basel. Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"2024050214454721800_b1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"2024050214454721800_b2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-199903000-00001","article-title":"The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital","volume":"78","author":"Johns","year":"1999","journal-title":"Medicine"},{"key":"2024050214454721800_b3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"1 Seventh Inter","key":"2024050214454721800_b4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"2024050214454721800_b5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2024050214454721800_b6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-0030-1262211","article-title":"Cardiac sarcoidosis","volume":"31","author":"Nunes","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"2024050214454721800_b7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.revmed.2016.03.003","article-title":"Cardiac sarcoidosis: diagnosis and therapeutic challenges","volume":"38","author":"Cohen Aubart","year":"2017","journal-title":"Rev Med Interne"},{"key":"2024050214454721800_b8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res"},{"key":"2024050214454721800_b9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2024050214454721800_b10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2024050214454721800_b11","first-page":"949","article-title":"Advances in imaging for diagnosis and management of cardiac sarcoidosis","volume":"16","author":"Aggarwal","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024050214454721800_b12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"2024050214454721800_b13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1378\/chest.107.2.330","article-title":"Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis","volume":"107","author":"Okayama","year":"1995","journal-title":"Chest"},{"key":"2024050214454721800_b14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","article-title":"FDG PET\/CT in infection and inflammation--current and emerging clinical applications","volume":"70","author":"Vaidyanathan","year":"2015","journal-title":"Clin Radiol"},{"key":"2024050214454721800_b15","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"7","author":"Yamada","year":"1995","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b16","first-page":"1551","article-title":"FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models","volume":"42","author":"Mochizuki","year":"2001","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI115780","article-title":"Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo","volume":"89","author":"Nuutila","year":"1992","journal-title":"J Clin Invest"},{"key":"2024050214454721800_b18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1253\/circj.CJ-14-0250","article-title":"Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases","volume":"78","author":"Miyagawa","year":"2014","journal-title":"Circ J"},{"key":"2024050214454721800_b19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024050214454721800_b20","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RLU.0b013e31827a27df","article-title":"18)F-FDG PET\/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study","volume":"38","author":"Ambrosini","year":"2013","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b21","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"2024050214454721800_b23","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"2024050214454721800_b25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024050214454721800_b26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.108.055616","article-title":"Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET\/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation","volume":"50","author":"Wykrzykowska","year":"2009","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res"},{"key":"2024050214454721800_b29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","article-title":"The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"key":"2024050214454721800_b31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7878\/jjsogd.35.31","article-title":"Recent advancement in diagnostic imaging around cardiac sarcoidosis","volume":"35","author":"Miyagawa","year":"2015","journal-title":"JJSOGD"},{"key":"2024050214454721800_b32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1095-0397(01)00062-0","article-title":"Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction","volume":"4","author":"Lum","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"2024050214454721800_b33","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00330-012-2478-2","article-title":"Suppression of myocardial 18F-FDG uptake with a preparatory \"Atkins-style\" low-carbohydrate diet","volume":"22","author":"Coulden","year":"2012","journal-title":"Eur Radiol"},{"key":"2024050214454721800_b34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b35","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","article-title":"Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet","volume":"190","author":"Williams","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"2024050214454721800_b36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2013.05.004","article-title":"Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet","volume":"62","author":"Kobayashi","year":"2013","journal-title":"J Cardiol"},{"key":"2024050214454721800_b37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2967\/jnmt.110.076489","article-title":"Suppression of 18F-FDG myocardial uptake using a Fat-Allowed, Carbohydrate-Restricted diet","volume":"39","author":"Balink","year":"2011","journal-title":"J Nucl Med Technol"},{"key":"2024050214454721800_b38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and Very-Low-Carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12350-009-9179-5","article-title":"Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial","volume":"17","author":"Cheng","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b40","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2967\/jnumed.114.138594","article-title":"A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging","volume":"55","author":"Demeure","year":"2014","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b41","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00259-011-1873-2","article-title":"Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection","volume":"38","author":"Gaeta","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050214454721800_b42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2016","journal-title":"Journal of Nuclear Medicine"},{"key":"2024050214454721800_b43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC Expert Consensus Document on the Role of 18 F-FDG PET\/CT in Cardiac Sarcoid Detection and Therapy Monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b44","first-page":"336","article-title":"Sperry prognostic impact of extent, severity","volume":"11","author":"Brett","year":"2018","journal-title":"and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis ACC: Cardiovascular Imaging"},{"key":"2024050214454721800_b45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12149-014-0860-7","article-title":"Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis","volume":"28","author":"Manabe","year":"2014","journal-title":"Ann Nucl Med"},{"key":"2024050214454721800_b47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b48","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"25","author":"Flores","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050214454721800_b50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b51","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050214454721800_b52","doi-asserted-by":"crossref","first-page":"81.e9","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clinical Radiology"},{"key":"2024050214454721800_b53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00259-010-1586-y","article-title":"Hybrid cardiac imaging: SPECT\/CT and PET\/CT. A joint position statement by the European association of nuclear medicine (EANM), the European Society of cardiac radiology (ESCR) and the European Council of nuclear cardiology (ECNC","volume":"38","author":"Flotats","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050214454721800_b54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.pcad.2015.02.002","article-title":"Advances in SPECT and PET hardware","volume":"57","author":"Slomka","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"2024050214454721800_b55","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/CIRCULATIONAHA.114.011000","article-title":"Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography\/magnetic resonance imaging","volume":"130","author":"von Olshausen","year":"2014","journal-title":"Circulation"},{"key":"2024050214454721800_b56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/RLI.0000000000000131","article-title":"Segmentation-based attenuation correction in positron emission tomography\/magnetic resonance: Erroneous tissue identification and its impact on positron emission tomography interpretation","volume":"50","author":"Brendle","year":"2015","journal-title":"Invest Radiol United States"},{"key":"2024050214454721800_b57","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"19","author":"Wisenberg","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"2024050214454721800_b58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/eurheartj\/eht335","article-title":"Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment","volume":"35","author":"Schneider","year":"2014","journal-title":"Eur Heart J"},{"key":"2024050214454721800_b59","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1097\/RLU.0000000000001669","article-title":"Initial experience with simultaneous 18F-FDG PET\/MRI in the evaluation of cardiac sarcoidosis and myocarditis","volume":"42","author":"Hanneman","year":"2017","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Garrett","year":"2018","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"2024050214454721800_b61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024050214454721800_b62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"The Lancet"},{"key":"2024050214454721800_b63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","article-title":"Cardiac sarcoidosis","volume":"123","author":"Tan","year":"2019","journal-title":"Am J Cardiol"},{"key":"2024050214454721800_b64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b65","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"2024050214454721800_b66","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/RLU.0b013e31828731f5","article-title":"Responsiveness of FDG PET\/CT to treatment of patients with active chronic sarcoidosis","volume":"38","author":"Sobic-Saranovic","year":"2013","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b67","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s12350-012-9550-9","article-title":"Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT","volume":"19","author":"Matthews","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b68","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by \u00b9\u2078F- fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2024050214454721800_b69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12350-012-9668-9","article-title":"The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis","volume":"20","author":"Mc Ardle","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in \u00b9\u2078F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024050214454721800_b72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-018-0447-8","article-title":"Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?","volume":"8","author":"Furuya","year":"2018","journal-title":"EJNMMI Res"},{"key":"2024050214454721800_b73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024050214454721800_b74","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; a systematic review and meta-analysis","volume":"336","author":"Kim","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"2024050214454721800_b75","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s002590050297","article-title":"Somatostatin receptor imaging in patients with sarcoidosis","volume":"25","author":"Kwekkeboom","year":"1998","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"2024050214454721800_b76","first-page":"44p","article-title":"Somatostatin receptor scintigraphy in patients with sarcoidosis: comparison with gallium-67 scintigraphy","volume":"39","author":"Lebtahi","year":"1998","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b77","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"Eur Heart J"},{"key":"2024050214454721800_b78","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"2024050214454721800_b79","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with (68)Ga-DOTATOC in sarcoidosis: comparison with (67)Ga-scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"2024050214454721800_b80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ehf2.12243","article-title":"Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis","volume":"5","author":"Pizarro","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2024050214454721800_b81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT - A comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"2024050214454721800_b82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"2024050214454721800_b83","article-title":"Bokhari S. F-18 sodium fluoride PET\/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis","author":"Weinberg","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000000653","article-title":"18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement","volume":"40","author":"Norikane","year":"2015","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.107.044578","article-title":"Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT","volume":"49","author":"Zhao","year":"2008","journal-title":"J Nucl Med"},{"key":"2024050214454721800_b86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18 F-FLT and 18 F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"2024050214454721800_b87","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RLU.0000000000002059","article-title":"11C-4DST PET\/CT imaging of cardiac sarcoidosis: comparison with 18F-FDG and cardiac MRI","volume":"43","author":"Hotta","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2024050214454721800_b88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12350-016-0495-2","article-title":"18 F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis","volume":"24","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2024050214454721800_b89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/5584_2015_144","article-title":"Expression of HIF-1A\/VEGF\/ING-4 axis in pulmonary sarcoidosis","volume":"866","author":"Piotrowski","year":"2015","journal-title":"Adv Exp Med Biol"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1100\/20190247\/57378400\/bjr.20190247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1100\/20190247\/57378400\/bjr.20190247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:02:59Z","timestamp":1714662179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190247\/7449127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":89,"journal-issue":{"issue":"1100","published-online":{"date-parts":[[2019,6,5]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190247","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8,1]]},"published":{"date-parts":[[2019,6,5]]},"article-number":"20190247"}}